Harbour Investments, Inc. Galapagos Nv Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$47.03 - $57.12 $19,188 - $23,304	-408 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $3,599 - $4,843	69 Added 20.35%	408 $21,000
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $3,925 - $4,750	-57 Reduced 14.39%	339 $23,000
Q1 2021 Aug 17, 2021	BUY	$76.15 - $111.94 $29,622 - $43,544	389 Added 5557.14%	396 $31,000
Q1 2021 May 12, 2021	BUY	$76.15 - $111.94 $533 - $783	7 New	7 $1,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.79B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.